Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.

<h4>Purpose</h4>The purpose of our study was to determine whether the amounts of circulating DNA (cDNA) could discriminate between NSCLC patients and healthy individuals and assess its value as a prognostic marker of this disease.<h4>Methods</h4>We conducted a study of 309 in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Raquel Catarino, Ana Coelho, António Araújo, Mónica Gomes, Augusto Nogueira, Carlos Lopes, Rui Medeiros
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/b2d8ee92bc5d4973856f7f6fe9fb1e9f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:<h4>Purpose</h4>The purpose of our study was to determine whether the amounts of circulating DNA (cDNA) could discriminate between NSCLC patients and healthy individuals and assess its value as a prognostic marker of this disease.<h4>Methods</h4>We conducted a study of 309 individuals and the cDNA levels were assessed through real-time PCR methodology.<h4>Results</h4>We found increased cDNA levels in NSCLC patients compared to control individuals. We also found a decreased overall survival time in patients presenting high cDNA levels, when compared to lower cDNA concentrations.<h4>Conclusions</h4>Quantification of cDNA may be a good tool for NSCLC detection with potential for clinical applicability.